Mcnease Drugs Co
Community/Retail Pharmacy
103 Medical Park Ln, Suite B, Huntsville
Texas, 77340-4976
936-293-8333 936-293-8641
Mcnease Drugs Co is an authorized DME supplier for medicare equipments and products.
Mcnease Drugs Co is a Community/Retail Pharmacy in Huntsville, Texas. It is located at 103 Medical Park Ln, Suite B, Huntsville and it's customer support contact number is 936-293-8333. The authorized person of Mcnease Drugs Co is Daniel Mcnease, RPH who is Owner of the pharmacy and his contact number is 936-293-8333. Active license number of Mcnease Drugs Co is 20486 for Community/Retail Pharmacy in Texas. Mcnease Drugs Co accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Mcnease Drugs Co is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Mcnease Drugs Co type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Mcnease Drugs Co |
| Type: | Community/Retail Pharmacy |
| Location: | 103 Medical Park Ln, Suite B, Huntsville, Texas, 77340-4976 |
| Phone: | 936-293-8333 |
| Fax: | 936-293-8641 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Daniel Mcnease |
| Credentials: | RPH |
| Position: | Owner |
| Contact Number: | 936-293-8333 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1215973680 |
| NPI Enumeration Date: | 22 Jun, 2006 |
| NPI Last Update On: | 20 Feb, 2017 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mcnease Drugs Co are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 20486 | Texas | Primary | |
| Long Term Care Pharmacy | | | Secondary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| VP1450022 | Medicaid | Texas | |
| 2105428 | Other | | Pk |
Medicare Enrollment:
Mcnease Drugs Co is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 6709997638 | O20100930034764 | Mcnease Drugs Co | DME SUPPLIER - PHARMACY |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 103 Medical Park Ln, Suite B Huntsville, Texas |
| Zip: | 77340-4976 |
| Phone Number: | 936-293-8333 |
| Fax Number: | 936-293-8641 |
Patients can reach Mcnease Drugs Co at
103 Medical Park Ln, Suite B, Huntsville, Texas or can
call on customer care at 936-293-8333.
Comments/ Reviews:
Read all the reviews posted for Mcnease Drugs Co below. You may also share your own experience with Mcnease Drugs Co. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.